Topical management of striae distensae (stretch marks): prevention and therapy of striae rubrae and albae

Por Ud‐Din, S., McGeorge, D., Bayat, A.
Publicado no J Eur Acad Dermatol Venereol (2015)

Epidemiology of Cutaneous Sarcoidosis, 1976–2013: A Population Based Study from Olmsted County, Minnesota

Por Ungprasert, P., Wetter, D.A., Crowson, C.S., Matteson, E.L.
Publicado no J Eur Acad Dermatol Venereol (2016)

Lentigo maligna – anatomic location as a potential risk factor for recurrences after non‐surgical treatment

Por Greveling, K., van der Klok, Th., van Doorn, M.B.A., Noordhoek Hegt, V., Prens, E.P.
Publicado no J Eur Acad Dermatol Venereol (2016)

Detection of desmoplastic melanoma with dermoscopy and reflectance confocal microscopy

Por Maher, N.G., Solinas, A., Scolyer, R.A., Puig, S., Pellacani, G., Guitera, P.
Publicado no J Eur Acad Dermatol Venereol (2017)

Papulopustular rosacea and rosacea‐like demodicosis: two phenotypes of the same disease?

Por Forton, F.M.N., De Maertelaer, V.
Publicado no J Eur Acad Dermatol Venereol (2018)

Comparison of fungal fluorescent staining and ITS rDNA PCR‐based sequencing with conventional methods for the diagnosis of onychomycosis

Por Bao, F., Fan, Y., Sun, L., Yu, Y., Wang, Z., Pan, Q., Yu, C., Liu, H., Zhang, F.
Publicado no J Eur Acad Dermatol Venereol (2018)

Characterization of hyaluronan and TSG-6 in skin scarring: differential distribution in keloid scars, normal scars and unscarred skin

Por Tan, KT, McGrouther, DA, Day, AJ, Milner, CM, Bayat, A
Publicado em 2011

Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACH

Por Poulin, Y, Crowley, JJ, Langley, RG, Unnebrink, K, Goldblum, OM, Valdecantos, WC
Publicado no J Eur Acad Dermatol Venereol (2014)

A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body

Por Pellacani, G., Peris, K., Guillen, C., Clonier, F., Larsson, T., Venkata, R., Puig, S.
Publicado no J Eur Acad Dermatol Venereol (2015)

Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient‐reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, control...

Por Thaçi, D., Kimball, A., Foley, P., Poulin, Y., Levi, E., Chen, R., Feldman, S.R.
Publicado no J Eur Acad Dermatol Venereol (2016)

Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis

Por Strohal, R, Kirby, B, Puig, L
Publicado no J Eur Acad Dermatol Venereol (2014)

Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoria...

Por Gilet, H, Roborel de Climens, A, Arnould, B, Bachelez, H, Bagot, M, Beaulieu, P, Joly, P, Jullien, D, Le Maître, M, Ortonne, JP, Paul, C, Thibout, E
Publicado no J Eur Acad Dermatol Venereol (2015)

A cross‐sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP)

Por Delany, E., Gormley, G., Hughes, R., McCarthy, S., Kirthi, S., Markham, T., Tobin, A.‐M., Murphy, M., Kirby, B.
Publicado no J Eur Acad Dermatol Venereol (2017)

Analysis of treatment goal alignment between Japanese psoriasis patients and their paired treating physicians

Por Okubo, Y., Tsuruta, D., Tang, A.C., Inoue, S., Torisu‐Itakura, H., Hanada, T., Ohtsuki, M.
Publicado no J Eur Acad Dermatol Venereol (2017)

Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, rand...

Por Ascher, B, Hoffmann, K, Walker, P, Lippert, S, Wollina, U, Havlickova, B
Publicado no J Eur Acad Dermatol Venereol (2014)

Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study

Por Layton, A.M., Schaller, M., Homey, B., Hofmann, M.A., Bewley, A.P., Lehmann, P., Nohlgård, C., Sarwer, D.B., Kerrouche, N., Ma, Y.M.
Publicado no J Eur Acad Dermatol Venereol (2015)

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL stu...

Por Hong, C‐H., Papp, K.A., Lophaven, K.W., Skallerup, P., Philipp, S.
Publicado no J Eur Acad Dermatol Venereol (2017)

Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis

Por Griffiths, C.E.M., Vender, R., Sofen, H., Kircik, L., Tan, H., Rottinghaus, S.T., Bachinsky, M., Mallbris, L., Mamolo, C.
Publicado no J Eur Acad Dermatol Venereol (2016)

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

Por Blauvelt, A., Papp, K.A., Sofen, H., Augustin, M., Yosipovitch, G., Katoh, N., Mrowietz, U., Ohtsuki, M., Poulin, Y., Shrom, D., Burge, R., See, K., Mallbris, L., Gordon, K.B.
Publicado no J Eur Acad Dermatol Venereol (2017)